Does elevated SHBG reduce free and bioavailable testosterone?

Sex hormone-binding globulin (SHBG) is the primary plasma glycoprotein regulating the distribution of circulating androgens. In aging men, understanding the dynamics of SHBG binding is crucial for evaluating true androgen status.

Physiological mechanisms of androgen binding

• High-affinity binding: SHBG binds circulating testosterone with an exceptionally high association constant ($K_a \approx 1 \times 10^9$ L/mol), dominating the equilibrium dynamics of sex steroids in the bloodstream.
• Reduction of active fractions: Elevated circulating SHBG shifts this binding equilibrium, heavily favoring the bound state and directly reducing the concentrations of free (unbound) and bioavailable (free plus loosely albumin-bound) testosterone.
• Restricted tissue access: Under the free hormone hypothesis, protein-bound testosterone acts as a restricted reservoir, whereas only the free and bioavailable fractions can passively diffuse into target organs. Animal models expressing human SHBG confirm that while elevated SHBG increases total testosterone, it significantly reduces hormone entry into tissues and lowers target-organ androgen bioactivity.

Clinical implications in aging

• Age-related SHBG rise: Circulating SHBG levels naturally rise with advancing age. In a 60-year-old male, this elevation accelerates the decline of biologically active testosterone.
• Symptomatic deficiency with normal total levels: Because high SHBG sequesters circulating testosterone, individuals can experience clinical symptoms of tissue-level androgen deficiency—such as fatigue, decreased muscle mass, and erectile dysfunction—even when total testosterone measurements fall within normal clinical ranges. Relying on calculated free or bioavailable testosterone provides a more accurate diagnostic assessment of tissue-accessible hormone.

Bottom line

• Elevated SHBG binds testosterone with high affinity ($1 \times 10^9$ L/mol), reducing free and bioavailable fractions to limit tissue-accessible androgen availability. In aging men, this mechanism can induce symptomatic androgen deficiency despite normal total testosterone levels.